Joseph Piacentile, MD in Fort Lee, NJ - General Practice

Joseph Piacentile, MD is a General Practice physician based in Fort Lee, New Jersey. Joseph Piacentile is licensed to practice in New Jersey (license number 25MA04713900) and his current practice location is 177 Main Street, Fort Lee, New Jersey. He can be reached at his office (for appointments etc.) via phone at (201) 787-5010.

NPI number for Joseph Piacentile is 1265607410 and his current mailing address is 177 Main Street, Fort Lee, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1265607410.

Contact Information

	Joseph Piacentile, MD
	177 Main Street, Fort Lee, NJ 07024
	(201) 787-5010
	(201) 782-0224

Physician's Profile

Full Name	Joseph Piacentile
Gender	Male
Speciality	General Practice
Location	177 Main Street, Fort Lee, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1265607410
Provider Enumeration Date: 04/29/2008
Last Update Date: 04/29/2008

Medical Identifiers

Medical identifiers for Joseph Piacentile such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265607410	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	25MA04713900 (New Jersey)	Primary
208D00000X	General Practice	MD045563E (Pennsylvania)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joseph Piacentile is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Joseph Piacentile, MD 177 Main Street, Fort Lee, NJ 07024 Ph: (201) 787-5010	Joseph Piacentile, MD 177 Main Street, Fort Lee, NJ 07024 Ph: (201) 787-5010

News Archive

Research on naked mole-rats could pave way for new human pain therapies

In injuries and inflammation, naked mole-rats do not develop normal hypersensitivity to temperature stimuli.

Caltech researchers map out pathways of neurons responsible for Parkinson's motor impairments

Because billions of neurons are packed into our brain, the neuronal circuits that are responsible for controlling our behaviors are by necessity highly intermingled. This tangled web makes it complicated for scientists to determine exactly which circuits do what. Now, using two laboratory techniques pioneered in part at Caltech, Caltech researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments-such as difficulty walking-found in patients with Parkinson's disease.

Simcere Pharmaceutical Group to control a 50.77% stake in Jiangsu Yanshen

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

Helminthic parasites, like hookworm and liver flukes (schistosomiasis), affect an estimated 1 billion people worldwide. Infection from hookworm and schistosomiasis result in a combined loss of as much as 92 million disability-adjusted life years annually.

Scientists discover tumor-targeting neural stem cells

Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.

Joseph Piacentile, MD - General Practice in Fort Lee, NJ